By U.S. FDA Recalls — IMMEDIATE RELEASE – Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Read the original at U.S. FDA Recalls ↗
Auto-published by the finit.news Events monitor from U.S. FDA Recalls; summarized by AI and may contain errors — verify against the primary source. October 4, 2026.